Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
RARRES1 Biologics Sequence Review Report 2026: Retinoic acid receptor responder protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RARRES1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MBL2 Biologics Sequence Review Report 2026: Mannose-binding protein C Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MBL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRM5 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FCN3 Biologics Sequence Review Report 2026: Ficolin-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FCN3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FOLR3 Biologics Sequence Review Report 2026: Folate receptor gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FOLR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GDF5 Biologics Sequence Review Report 2026: Growth/differentiation factor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GDF5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
VIPR2 Biologics Sequence Review Report 2026: Vasoactive intestinal polypeptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of VIPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ACHE Biologics Sequence Review Report 2026: Acetylcholinesterase Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ACHE protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
VIPR1 Biologics Sequence Review Report 2026: Vasoactive intestinal polypeptide receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of VIPR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TRPC1 Biologics Sequence Review Report 2026: Short transient receptor potential channel 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TRPC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
UNC5C Biologics Sequence Review Report 2026: Netrin receptor UNC5C Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of UNC5C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TSHR Biologics Sequence Review Report 2026: Thyrotropin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TSHR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
238
239
240
241
242
>>
1905
>